CorMedix Inc. Gross Profit

• CorMedix Inc. showed an increase of +584.5% in Gross Profit from 2024 to 2025.
• This data is from CorMedix Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
• XBRL data for this metric is available from 2012 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2013: $0.00 | Q2 2013: $0.00 | Q3 2013: $0.00 | Q1 2014: -$68.8 thousand | Q2 2014: -$14.8 thousand | Q3 2014: $15.8 thousand | Q1 2015: $14.00 | Q2 2015: $18.00 | Q3 2015: $1.00 | Q4 2015: -$141.00 | Q1 2016: -$8.8 thousand | Q2 2016: -$170.7 thousand | Q3 2016: $529.00 | Q4 2016: $36.00 | Q1 2017: -$54.0 thousand | Q2 2017: $118.1 thousand | Q3 2017: -$5.6 thousand | Q1 2018: -$5.4 thousand | Q2 2018: -$26.1 thousand | Q3 2018: $60.1 thousand | Q1 2019: -$63.3 thousand | Q2 2019: $14.1 thousand | Q3 2019: -$19.5 thousand | Q1 2020: $25.5 thousand | Q2 2020: -$2.7 thousand | Q3 2020: $13.1 thousand | Q1 2021: $26.9 thousand | Q2 2021: -$6.2 thousand | Q3 2021: $12.9 thousand | Q1 2022: $6.1 thousand | Q2 2022: $20.9 thousand | Q3 2022: $5.3 thousand | Q1 2024: -$818.5 thousand | Q2 2024: $296.3 thousand | Q3 2024: $10.77 million | Q1 2025: $37.48 million | Q2 2025: $37.87 million | Q3 2025: $93.08 million.
• Historical annual values: Fiscal year 2025: $275.75 million | Fiscal year 2024: $40.28 million | Fiscal year 2022: $61.7 thousand | Fiscal year 2021: $42.0 thousand | Fiscal year 2020: $34.4 thousand | Fiscal year 2019: -$90.0 thousand | Fiscal year 2018: $33.0 thousand | Fiscal year 2017: $214.4 thousand | Fiscal year 2016: -$142.6 thousand | Fiscal year 2015: -$108.6 thousand | Fiscal year 2014: -$256.5 thousand | Fiscal year 2013: -$199.6 thousand | Fiscal year 2012: $0.00.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026